113 related articles for article (PubMed ID: 9769130)
1. Prognostic significance of standardized AgNOR analysis in early and advanced gastric carcinomas.
Giuffrè G; Caruso RA; Barresi G; Tuccari G
Virchows Arch; 1998 Sep; 433(3):261-6. PubMed ID: 9769130
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.
Ofner D; Bier B; Heinrichs S; Berghorn M; Dünser M; Hagemann HA; Langer D; Böcker W; Schmid KW
Breast Cancer Res Treat; 1996; 39(2):165-76. PubMed ID: 8872325
[TBL] [Abstract][Full Text] [Related]
3. The AgNOR quantity as prognostic parameter in choroidal melanomas: a standardised analysis.
Tuccari G; Giménez-Mas JA; Fedele F; Del-Agua C; Melcon B; Trombetta CJ; Giuffrè G
Anal Cell Pathol; 1999; 19(3-4):163-8. PubMed ID: 10866278
[TBL] [Abstract][Full Text] [Related]
4. Standardized AgNOR analysis as a prognostic parameter in endometrial carcinoma, endometrioid type.
Giuffrè G; Fulcheri E; Gualco M; Fedele F; Tuccari G
Anal Quant Cytol Histol; 2001 Feb; 23(1):31-9. PubMed ID: 11233741
[TBL] [Abstract][Full Text] [Related]
5. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
[TBL] [Abstract][Full Text] [Related]
6. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
[TBL] [Abstract][Full Text] [Related]
7. AgNOR quantity as a prognostic tool in hyperplastic and neoplastic parathyroid glands.
Tuccari G; Abbona GC; Guiffrè G; Papotti M; Gasparri G; Barresi G; Bussolati G
Virchows Arch; 2000 Sep; 437(3):298-303. PubMed ID: 11037351
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Two Dimensional AgNOR Evaluation in Local Advanced Rectal Cancer Treated with Chemoradiotherapy.
Gundog M; Yildiz OG; Imamoglu N; Aslan D; Aytekin A; Soyuer I; Soyuer S
Asian Pac J Cancer Prev; 2015; 16(18):8155-61. PubMed ID: 26745054
[TBL] [Abstract][Full Text] [Related]
9. Improvement of breast cancer prognostication using cell kinetic-based silver-stainable nucleolar organizer region quantification of the MIB-1 positive tumor cell compartment.
Biesterfeld S; Farokhzad F; Klüppel D; Schneider S; Hufnagl P
Virchows Arch; 2001 May; 438(5):478-84. PubMed ID: 11407476
[TBL] [Abstract][Full Text] [Related]
10. Standardized AgNOR analysis in actinic keratosis.
Tuccari G; Giuffrè G; Catalano A; Lentini M; Batolo D
Am J Dermatopathol; 2001 Oct; 23(5):407-12. PubMed ID: 11801772
[TBL] [Abstract][Full Text] [Related]
11. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
Chiusa L; Galliano D; Formiconi A; Di Primio O; Pich A
Cancer; 1997 May; 79(10):1956-63. PubMed ID: 9149023
[TBL] [Abstract][Full Text] [Related]
12. Silver-stained nucleolar organizer regions (AgNORs) as a prognostic value in malignant melanoma.
Barzilai A; Goldberg I; Yulash M; Pavlotsky F; Zuckerman A; Trau H; Azizi E; Kopolovic J
Am J Dermatopathol; 1998 Oct; 20(5):473-7. PubMed ID: 9790108
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of standardized AgNOR analysis and Ki-67 immunostaining in gastrointestinal stromal tumors.
Rodolico V; Martorana A; Gulotta G; Diana G; Leonardi V; Cocorullo G; Ajello F
Anal Quant Cytol Histol; 2003 Aug; 25(4):199-209. PubMed ID: 12961826
[TBL] [Abstract][Full Text] [Related]
14. Standardized staining and analysis of argyrophilic nucleolar organizer region associated proteins (AgNORs) in radically resected colorectal adenocarcinoma--correlation with tumour stage and long-term survival.
Ofner D; Riedmann B; Maier H; Hittmair A; Rumer A; Tötsch M; Spechtenhauser B; Böcker W; Schmid KW
J Pathol; 1995 Apr; 175(4):441-8. PubMed ID: 7790997
[TBL] [Abstract][Full Text] [Related]
15. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
16. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.
Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of AgNORs in breast cancer].
Aubele M; Auer G; Jütting U
Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
[TBL] [Abstract][Full Text] [Related]
18. Actinic keratosis associated with squamous and basal cell carcinomas: an evaluation of neoplastic progression by a standardized AgNOR analysis.
Giuffrè G; Barresi V; Catalano A; Cappiello A; Stagno d'Alcontres F; Tuccari G
Eur J Histochem; 2008; 52(1):53-60. PubMed ID: 18502723
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum.
Rüschoff J; Bittinger A; Neumann K; Schmitz-Moormann P
Pathol Res Pract; 1990 Feb; 186(1):85-91. PubMed ID: 1690415
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implication of silver-binding nucleolar organizer regions (AgNORs) in oral squamous cell carcinoma.
Sano K; Takahashi H; Fujita S; Inokuchi T; Pe MB; Okabe H; Tsuda N
J Oral Pathol Med; 1991 Feb; 20(2):53-6. PubMed ID: 1707972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
